NYSE:BTX

Brooklyn Immunotherapeutics Stock Forecast

etoro logo Buy BTX
*Your capital is at risk
$9.42
+0.0800 (+0.86%)
At Close: Jun 22, 2026
AI Analysis AI Analysis of BTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BTX to Watchlist?
Some Reasons Why To Add BTX:
  • Bullish trend confirmed on both short and long timeframes
  • Consistently positive technical signals over the last month
  • +40.8% YTD performance
PDF

Brooklyn Immunotherapeutics Inc stock upgraded to Strong Buy Candidate
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Apr 08, 2026 Gain 36.52%

The Brooklyn Immunotherapeutics Inc stock price gained 0.86% on the last trading day (Monday, 22nd Jun 2026), rising from $9.34 to $9.42. During the last trading day the stock fluctuated 1.34% from a day low at $9.32 to a day high of $9.44. The price has risen in 6 of the last 10 days and is up by 7.53% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 228 thousand more shares were traded than the day before. In total, 675 thousand shares were bought and sold for approximately $6.36 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 44.03% during the next 3 months and, with a 90% probability hold a price between $12.98 and $14.37 at the end of this 3-month period.

BTX Signals & Forecast

The Brooklyn Immunotherapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.18 and $8.78. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 8.65%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The stock had a Golden Star Signal on Tuesday, January 27, 2026 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Tuesday, January 27, 2026 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Brooklyn Immunotherapeutics Inc stock

Brooklyn Immunotherapeutics Inc finds support from accumulated volume at $8.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.125 (1.34%) between high and low. For the last week, the stock has had daily average volatility of 2.08%.

Our recommended stop-loss: $9.05 (-3.92%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (BTX) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Brooklyn Immunotherapeutics Inc to open at $9.39, and during the day (based on 14 day Average True Range), to move between $9.29 and $9.55, which gives a possible trading interval of +/-$0.263 (+/-2.83%) up or down from last closing price. If Brooklyn Immunotherapeutics Inc takes out the full calculated possible swing range there will be an estimated 2.83% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $8.95, some $0.470 (4.99%) from the current price of $9.42, our system finds the risk reward attractive.

Is Brooklyn Immunotherapeutics Inc stock A Buy?

Brooklyn Immunotherapeutics Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 6.159 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $9.39 ( 0.301%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BTX Performance

Trading levels for BTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.52 1.03%
R2 9.47 0.519%
R1 9.44 0.206%
Price 9.42
S1 9.34 -0.81%
S2 9.31 -1.12%
S3 9.27 -1.63%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 9.42
S1 8.95 -4.99%
S2 7.94 -15.71%
S3 7.40 -21.44%

BTX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 15, 2026 Sep 15, 2026 Sep 30, 2026 $0.0525 0.601%
2 Aug 14, 2026 Aug 14, 2026 Aug 31, 2026 $0.0525 0.601%
3 Jul 15, 2026 Jul 15, 2026 Jul 31, 2026 $0.0525 0.601%
4 Jun 15, 2026 Jun 15, 2026 Jun 30, 2026 $0.0525 0.781%
5 May 15, 2026 May 15, 2026 May 29, 2026 $0.0525 0.781%

FAQ

What is the symbol for Brooklyn Immunotherapeutics Inc Stock and on which exchange is it traded?
The symbol for Brooklyn Immunotherapeutics Inc is BTX and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Brooklyn Immunotherapeutics Inc Stock?
Brooklyn Immunotherapeutics Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy Brooklyn Immunotherapeutics Inc Stock?
Brooklyn Immunotherapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Brooklyn Immunotherapeutics Inc Stock.

What's the current price of Brooklyn Immunotherapeutics Inc Stock?
As of the end of day on the Jun 22, 2026, the price of an Brooklyn Immunotherapeutics Inc (BTX) share was $9.42.

What is the 52-week high and low for Brooklyn Immunotherapeutics Inc Stock?
The 52-week high for Brooklyn Immunotherapeutics Inc Stock is $9.44 and the 52-week low is $6.13.

What is the market capitalization of Brooklyn Immunotherapeutics Inc Stock?
As of the Jun 22, 2026, the market capitalization of Brooklyn Immunotherapeutics Inc is 1.099B.
Click to get the best stock tips daily for free!
ABOUT BROOKLYN IMMUNOTHERAPEUTICS INC
Brooklyn Immunotherapeutics
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics,...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE